Fluproquazone
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
4-(4-fluorophenyl)-7-methyl-1-propan-2-ylquinazolin-2-one
|
|
| Identifiers | |
| CAS Number | 40507-23-1 |
| ATC code | none |
| PubChem | CID 38503 |
| ChemSpider | 35289  |
| UNII | U4K85O58HD |
| KEGG | D04229 |
| Chemical data | |
| Formula | C18H17FN2O |
| Molar mass | 296.339 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Fluproquazone (trade name Tormosyl, RF 46-790 ) was a quinazolinone derivative with potent analgesic, antipyretic, and anti-inflammatory effects discovered by Sandoz.[1][2][3][4] It was withdrawn during development due to liver toxicity.[5]:370[6]:520
References[edit]
- ^ Haanaes HR, et al RF 46-790 versus paracetamol: effect on post-operative pain. Int J Clin Pharmacol Ther Toxicol. 1986 Nov;24(11):598-601. PMID 3491794
- ^ Mohing W, Suckert R, Lataste X. Comparative study of fluproquazone in the management of post-operative pain. Arzneimittelforschung. 1981;31(5a):918-20.
- ^ Wheatley D. Analgesic properties of fluproquazone. Rheumatology and Rehabilitation. 1982 May;21(2):98-100.
- ^ Fankhauser S, Laube W, Marti HR, Schultheiss HR, Vogtlin J, von Graffenried B. Antipyretic activity of fluproquazone in man. Arzneimittelforschung. 1981;31(5a):934-5.
- ^ Lewis JH and Stine JG. Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists, Ch 22 in Drug-induced Liver Disease (Third Edition). Eds Neil Kaplowitz and Laurie D. DeLeve. Elsevier Inc, 2013. ISBN 9780123878175
- ^ Hyman J. Zimmerman. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. Lippincott Williams & Wilkins, 1999. ISBN 9780781719520
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
